Cortexolone-17α-propionate (CP) is a topically active antiandrogen useful in the treatment of skin disorders. In the solid state, three anhydrous forms of this drug (CPI, CPII and CPIII) occur, together with one hydrated crystal (CPW). The single crystal structure of the monohydrated phase, CPW, compared with that of the anhydrous form CPIII, shows a markedly different solid state behavior. These latter pseudopolymorphic forms have also been fully characterized by spectroscopic methods.
Full spectroscopic characterization of two crystal pseudopolymorphic forms of the antiandrogen cortexolone 17α-propionate for topic application / P. Ferraboschi, M. Sala, R. Stradi, L. Ragonesi, C. Gagliardi, P. Lanzarotti, E.M. Ragg, M. Mori, F. Meneghetti. - In: STEROIDS. - ISSN 0039-128X. - 128(2017), pp. 95-104. [10.1016/j.steroids.2017.09.003]
Full spectroscopic characterization of two crystal pseudopolymorphic forms of the antiandrogen cortexolone 17α-propionate for topic application
P. Ferraboschi;R. Stradi;L. Ragonesi;E..M. Ragg;M. Mori;F. Meneghetti
2017
Abstract
Cortexolone-17α-propionate (CP) is a topically active antiandrogen useful in the treatment of skin disorders. In the solid state, three anhydrous forms of this drug (CPI, CPII and CPIII) occur, together with one hydrated crystal (CPW). The single crystal structure of the monohydrated phase, CPW, compared with that of the anhydrous form CPIII, shows a markedly different solid state behavior. These latter pseudopolymorphic forms have also been fully characterized by spectroscopic methods.File | Dimensione | Formato | |
---|---|---|---|
steroids_2017.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.35 MB
Formato
Adobe PDF
|
1.35 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.